Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benzalkonium Chloride for Oral Bacteria in COPD
NCT02269800Phase 4Unknown
- Sponsor
- Lustre Pharmaceutical Private Limited
- Start
- Oct 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of benzalkonium chloride in bacterial colonization, sponsored by Lustre Pharmaceutical Private Limited. Status: unknown.
02
Drugs
benzalkonium chloride
03
Conditions
bacterial colonization
Beyond the preview
Go deeper on NCT02269800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02269800.